Handler Bangkok Flight Services has achieved Good Distribution Practice (GDP) certification for its pharma facility at Suvarnabhumi International Airport.
BFS, which is a joint venture between SAT-owned WFS and Bangkok Airways, received its GDP certification from independent audit body Escem/TüV Rheinland following a two-day assessment of the pharma facility.
The pharma facility consists of three zones offering some 120 sq m of capacity, including 215 storage positions within controlled temperature ranges of 15-25°C and 2-8°C.
"This confirms the operation’s compliance with European Commission guidelines on GDP of medicinal products for human use, and the World Health Organization’s WHO TRS 1025 – Annex 7 for Good Storage & Distribution Practices for medical products," the handler said.
In 2024, BFS will increase the capacity of its pharma storage to support growing customer volumes.
This award takes WFS' number of GDP or IATA CEIV Pharma-certified facilities to 27, with two further locations in North America aiming for certification in the second and third quarters of 2024.
Stewart Sinclair, managing director of BFS, said: “BFS, WFS and SATS have a shared commitment to ensuring the safe and secure handling of temperature-controlled, life-enhancing pharma cargoes.
"This is evident by our investments in best-in-class pharma centres in Europe, Scandinavia, North America, the Middle East, India and Asia, and more certified facilities will join this network in 2024."
In addition to Bangkok, WFS, and other subsidiaries of the SATS Group, now operate certified pharma handling facilities in Amsterdam, Barcelona, Bangalore, Beijing PEK & PKX, Brussels, Cape Town, Copenhagen, Dallas Fort Worth, Dammam, Dublin, Frankfurt, Ho Chi Minh, Hong Kong, Jakarta, Johannesburg, Kuala Lumpur, London LHR & LGW, Madrid, Miami, Mumbai, Muscat, New York JFK, Paris CDG, Philadelphia.
https://www.aircargonews.net/services/ground-handler/bangkok-handler-bfs-lifts-its-import-cargo-embargo/
